CRISPR Therapeutics is a biotech company focused on gene-editing therapies using CRISPR-Cas9 technology to treat genetic diseases. Its research includes potential cures for sickle cell disease, cancer, and other genetic disorders.
Ticker code: CRSP
Sector: Healthcare | Industry: Biotechnology | Website: https://www.crisprtx.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $6,149,158,155 | $4,643,373,163 | 90950423.0 | 99.45 | $6,115,460,789 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $1,760,982,073 | $1,721,236,992 | $215,452,000 | -25.9 | -874.3 | -85.5 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| None | 8.1 | $90,273,752 | $174,707,825 | None | 0.0 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $67.610 | 0.6 | -8.6 | 9.6 | 4.4 | 78.5 | 41.1 |
CRSP Price Chart with Volume and 3EMA
CRSP Short Positions
No chart available for this company.
Click HERE to understand why the above moving averages have been chosen.